8PIZ image
Entry Detail
PDB ID:
8PIZ
EMDB ID:
Keywords:
Title:
Neisseria meningitidis Type IV pilus SB-DATDH variant bound to the C24 nanobody
Biological Source:
PDB Version:
Deposition Date:
2023-06-22
Release Date:
2024-04-03
Method Details:
Experimental Method:
Resolution:
2.75 Å
Aggregation State:
FILAMENT
Reconstruction Method:
HELICAL
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Pilin
Chain IDs:A
Chain Length:161
Number of Molecules:1
Biological Source:Neisseria meningitidis 8013
Polymer Type:polypeptide(L)
Description:C24 nanobody
Chain IDs:B
Chain Length:149
Number of Molecules:1
Biological Source:Vicugna pacos
Primary Citation
Cryo-EM structures of type IV pili complexed with nanobodies reveal immune escape mechanisms.
Nat Commun 15 2414 2414 (2024)
PMID: 38499587 DOI: 10.1038/s41467-024-46677-y

Abstact

Type IV pili (T4P) are prevalent, polymeric surface structures in pathogenic bacteria, making them ideal targets for effective vaccines. However, bacteria have evolved efficient strategies to evade type IV pili-directed antibody responses. Neisseria meningitidis are prototypical type IV pili-expressing Gram-negative bacteria responsible for life threatening sepsis and meningitis. This species has evolved several genetic strategies to modify the surface of its type IV pili, changing pilin subunit amino acid sequence, nature of glycosylation and phosphoforms, but how these modifications affect antibody binding at the structural level is still unknown. Here, to explore this question, we determine cryo-electron microscopy (cryo-EM) structures of pili of different sequence types with sufficiently high resolution to visualize posttranslational modifications. We then generate nanobodies directed against type IV pili which alter pilus function in vitro and in vivo. Cyro-EM in combination with molecular dynamics simulation of the nanobody-pilus complexes reveals how the different types of pili surface modifications alter nanobody binding. Our findings shed light on the impressive complementarity between the different strategies used by bacteria to avoid antibody binding. Importantly, we also show that structural information can be used to make informed modifications in nanobodies as countermeasures to these immune evasion mechanisms.

Legend

Protein

Chemical

Disease

Primary Citation of related structures